WeVote
Log In

Bill

Bill

HB 1416

Influenza prophylaxis; pharmacists initiation of treatment.

2026 Regular Session Introduced by Keith Hodges

Bill authorizes pharmacists to independently initiate influenza antiviral prophylaxis without physician prescription, expanding access but facing subcommittee rejection over scope-of-practice concerns.

Subcommittee recommends striking from the docket (9-Y 0-N)
0
WeVote Research Nonpartisan
Bill Summary · HB 1416

Legislative bill overview

HB 1416 would authorize Virginia pharmacists to initiate antiviral treatment for influenza prophylaxis without requiring a prior prescription from a physician. This expands the scope of practice for pharmacists to include independent clinical decision-making for flu prevention in eligible patients.

Why is this important

Pharmacists are accessible healthcare providers in most communities, and allowing them to initiate flu prophylaxis could expand treatment access—particularly in rural areas or for patients who cannot quickly see a doctor during flu season. However, the bill has already been recommended for removal from consideration by the relevant subcommittee, suggesting it faced significant legislative resistance.

Potential points of contention

  • Scope of practice concerns: Medical boards may argue that flu prophylaxis decisions require physician oversight and full patient medical history review to avoid contraindications and drug interactions
  • Liability and accountability: Unclear which party bears responsibility if a patient experiences adverse effects from independently initiated antiviral therapy
  • Patient safety protocols: Questions about what screening mechanisms and clinical guidelines would govern pharmacist decision-making in the absence of established protocols similar to those used by physicians

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.